Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease

Title
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Authors
Keywords
-
Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 25, Issue 2, Pages 61-77
Publisher
Mary Ann Liebert Inc
Online
2016-03-24
DOI
10.1089/ars.2015.6549

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started